Occult metastasis in sentinel lymph node in early-stage breast cancer;Metástase oculta em linfonodo sentinela no câncer de mama em estádios iniciais

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 9, 2008, Pages 432-436

  Piato, José Roberto Morales ^a,c   Pincerato, Kátia Maciel ^a,b   Da Silva Gomes, Vivian Carla ^a   Carvalho, Filomena Marino ^a,b   Da Silva Pinheiro, Walter ^a   Baracat, Edmund Chada ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratório Filomena Marino Carvalho   (Brazil)

^c UERJ Clinical Research   (Brazil)

Author keywords

Breast neoplasms surgery; Immunohistochemistry; Keratins; Neoplasm metastasis diagnosis; Sentinel lymph node biopsy

Indexed keywords

EID: 55749109730     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339(14):941-6.
2. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91(4):368-73.
3. Cody HS 3rd. Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol. 2003;10(101:1131-2.
4. Piato JRM, Barros ACSD, Nisida ACT, Buchpigel CA, Barros N, Pinotti JA. Emprego concomitante da localização radioguiada da lesão e do estudo do linfonodo sentinela para o carcinoma invasor de mama não palpável. Rev Bras Ginecol Obstet. 2003;25(9):655-9.
5. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41(2):231-7.
6. NaikAM, FeyJ, Gemignani M, Heerdt A, Montgomery L, PetrekJ, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240(3):462-8.
7. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80(7):1188-97.
8. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 6th ed. New York: Willey-Liss; 2002.
9. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer. 2000;88(5): 1099-107.
10. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol. 2002;55(12):926-31.
11. Klevesath MB, Bobrow LG, Pinder SE, Purushotham AD. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. Br J Cancer. 2005;92(12):2201-5.
12. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23 (7):1379-89.
13. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005;241(2): 319-25.
14. Houvenaeghel G, Nos C, Mignotte H, Classe JM, Giard S, Rouanet P, Lorca FP, JacquemierJ, Bardou VJ; Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol. 2006;24 (12):1814-22.
15. Holm M, Paaschburg B, Balslev E, Axelsson CK, Willemoe GL, Flyger HL. Intraoperative immunohistochemistry staining of sentinel nodes in breast cancer: Clinical and economical implications. Breast. 2008;17(4):372-5.